| Intrinsic Valuation of: MDLZ | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 3 | Market Cap | $89B | |||||
| 2021 | - | - (-) | P/E Ratio | 26 | Total Asset | $68B | |||||
| 2022 | $3B | - (-) | Net Income | $5B | Total Debt | $16B | |||||
| 2023 | $3B | -5.5% (-13.8%) | EBITDA | $8B | Total Liab | $42B | |||||
| 2024 | $4B | 20.0% (4.9%) | Opr Margin | 0.18 | Debt/Equity | 0.58 | |||||
| 2025 | $4B | -2.2% (-3.3%) | PreTax Margin | 16.90 | BV/Share | -12 | |||||
| 5Y Average FCF | $3B | 4.1% (-4.1%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (4.1%) | ||||||||||
| 2026 | $4B | MBG Intrinsic Value | $24 | ||||||||
| 2027 | $4B | ||||||||||
| 2028 | $4B | ||||||||||
| 2029 | $4B | ||||||||||
| 2030 | $4B | ||||||||||
| 2031 | $4B | ||||||||||
| Terminal Value | $93B | Net Worth/Share | $21 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $80B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $1B | $50 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $16B | WACC | 7.3% | 43 | 47 | 52 | 58 | 65 | |||
| Equity Value | $65B | 7.4% | 43 | 46 | 51 | 57 | 64 | ||||
| Shares Outstanding | 1,294,819,968 | 7.4% | 42 | 46 | 50 | 56 | 63 | ||||
| 7.9% | 38 | 41 | 45 | 49 | 55 | ||||||
| DCF Intrinsic Value | $50 | 8.4% | 34 | 37 | 40 | 44 | 48 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||